ViroGates Management
Management criteria checks 3/4
ViroGates' CEO is Jakob Knudsen, appointed in Apr 2011, has a tenure of 13.08 years. total yearly compensation is DKK1.60M, comprised of 86.1% salary and 13.9% bonuses, including company stock and options. directly owns 0.69% of the company’s shares, worth DKK295.55K. The average tenure of the management team and the board of directors is 6.2 years and 2.1 years respectively.
Key information
Jakob Knudsen
Chief executive officer
kr.1.6m
Total compensation
| CEO salary percentage | 86.1% |
| CEO tenure | 13.1yrs |
| CEO ownership | 0.7% |
| Management average tenure | 6.2yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans
Mar 06
We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely
Nov 21Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?
Jun 14We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate
Sep 19We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth
Apr 14We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth
Dec 30
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -kr.12m |
| Sep 30 2023 | n/a | n/a | -kr.11m |
| Jun 30 2023 | n/a | n/a | -kr.11m |
| Mar 31 2023 | n/a | n/a | -kr.10m |
| Dec 31 2022 | kr.2m | kr.1m | -kr.10m |
| Sep 30 2022 | n/a | n/a | -kr.12m |
| Jun 30 2022 | n/a | n/a | -kr.13m |
| Mar 31 2022 | n/a | n/a | -kr.16m |
| Dec 31 2021 | kr.2m | kr.1m | -kr.18m |
| Sep 30 2021 | n/a | n/a | -kr.18m |
| Jun 30 2021 | n/a | n/a | -kr.18m |
| Mar 31 2021 | n/a | n/a | -kr.17m |
| Dec 31 2020 | kr.2m | kr.1m | -kr.19m |
Compensation vs Market: Jakob's total compensation ($USD229.51K) is below average for companies of similar size in the Danish market ($USD389.47K).
Compensation vs Earnings: Jakob's compensation has been consistent with company performance over the past year.
CEO
Jakob Knudsen (55 yo)
13.1yrs
Tenure
kr.1,601,492
Compensation
Mr. Jakob Knudsen serves as Independent Director at ExpreS2ion Biotech Holding AB (publ) since 2021. He had been Director at ExpreS2ion Biotech Holding AB (publ) since April 19, 2017 until 2021. Mr. Knudse...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 13.1yrs | kr.1.60m | 0.69% DKK 295.6k | |
| Co-Founder & Chief Scientific Officer | 24.3yrs | no data | 2.23% DKK 949.1k | |
| Chief Financial Officer | 1.2yrs | no data | no data | |
| Vice President of Accounting | 4.6yrs | no data | no data | |
| Vice President of Global Sales & Marketing | 6.2yrs | no data | 0.062% DKK 26.5k | |
| Head of Marketing | no data | no data | no data |
6.2yrs
Average Tenure
60yo
Average Age
Experienced Management: VIRO's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Scientific Advisor | no data | no data | no data | |
| Non-Executive Director | no data | kr.106.25k | 0.11% DKK 46.0k | |
| Scientific Advisor | 17.3yrs | no data | no data | |
| Independent Chairman | 2.1yrs | no data | 0.082% DKK 34.9k | |
| Independent Director | 2.1yrs | kr.87.85k | no data |
2.1yrs
Average Tenure
61.5yo
Average Age
Experienced Board: VIRO's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.